1. Cost-Effectiveness Analysis

   • Mendel E. Singer

   Editorial 22 September 2012 Pages: 359 - 361

2. Perspectives on Patient-Reported Outcomes

   • Nancy Kline Leidy
   • Margaret Vernon

   Leading Article 22 September 2012 Pages: 363 - 370

3. Economic Evaluation of Interventions to Treat Opiate Dependence

   • Christopher M. Doran

   Review Article 22 September 2012 Pages: 371 - 393

   

4. Economic Evaluations in Rheumatoid Arthritis

   • Nick Bansback
   • Roberta Ara
   • Aslam Anis

   Review Article 22 September 2012 Pages: 395 - 408

   

5. Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer

   • Lieven Annemans

   Review Article 22 September 2012 Pages: 409 - 423

   

6. A Multicentre, Prospective Study to Evaluate Costs of Septic Patients in Brazilian Intensive Care Units

   • Ana M. C. Sogayar
   • Flavia R. Machado
   • Eliezer Silva

   Original Research Article 22 September 2012 Pages: 425 - 434

   

7. Updated Estimates of Survival and Cost Effectiveness for Imatinib versus Interferon-a Plus Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukaemia

   • Shelby D. Reed
   • Kevin J. Anstrom
   • Kevin A. Schulman

   Original Research Article 22 September 2012 Pages: 435 - 446